Navigation Links
Varian, Inc. Board of Directors Makes Officer Changes
Date:9/15/2008

PALO ALTO, Calif., Sept. 15 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) today announced that its Board of Directors has promoted Sean M. Wirtjes, Vice President and Controller, to a new position, Vice President, Finance and Treasurer, effective September 15, 2008. Wirtjes assumes the Treasurer position from G. Edward McClammy, who continues as the Company's Senior Vice President and Chief Financial Officer.

The Board of Directors appointed Robert W. Dean II to replace Wirtjes as the Company's Controller (which is the Company's principal accounting officer), also effective September 15, 2008. Dean joins the Company from Applied Materials, Inc., where he held various accounting and finance positions over 17 years, most recently as Director of Finance responsible for their revenue recognition and operations finance Centers of Excellence. Prior to joining Applied Materials, he was a senior auditor at PricewaterhouseCoopers LLP. Dean is a Certified Public Accountant, and earned a Masters in Business Administration from Santa Clara University and a Bachelor of Science in Accounting from San Jose State University.

Both Wirtjes and Dean will report to McClammy, the Company's Chief Financial Officer.

The Company also announced that the Board of Directors has promoted Michael Fitzgerald to corporate Vice President, Human Resources. Fitzgerald was previously Vice President, Human Resources for the Company's Scientific Instruments business. In this new position, Fitzgerald will report to Garry W. Rogerson, the Company's President and Chief Executive Officer.

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 4,000 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2007 sales of $921 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site: http://www.varianinc.com.

For More Information, Contact:

Investor Relations

Varian, Inc.

650.424.5471

ir@varianinc.com


'/>"/>
SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Varian, Inc. to Present at Thomas Weisel Partners 2008 Healthcare Conference
2. New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
3. New Turbomolecular Pumping System From Varian, Inc. Delivers Portable, Dry, Ultra-high Vacuum.
4. Varian, Inc. Reports Third Quarter 2008 Results
5. James T. Glover Appointed to Board of Directors of Varian, Inc.
6. New Capillary Column From Varian, Inc. Offers Durability and Performance for High Temperature GC and GC/MS
7. New FT-IR Spectrometer Series from Varian, Inc.
8. New Dual Cold Probe From Varian, Inc. Increases Sensitivity and Reduces Analysis Times for 13C NMR Experiments
9. Double Resonance Probe for Liquid State NMR Applications From Varian, Inc. Increases Productivity for Routine Analyses
10. New FTMS System From Varian, Inc. Offers Switchable LC and GC Sources and True Triple Quadrupole Capabilities
11. New Chromatography Detectors From Varian, Inc. Extend the Range of Universal Detection for HPLC and LC/MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
(Date:3/23/2017)... Kineta, Inc., a biotechnology company focused ... immuno-oncology, today announced the discovery and characterization of ... activate interferon response factor 3 (IRF3) via RIG-I ... regression in a murine colon carcinoma mouse model.  ... tumor regression to initial drug treatment were resistant ...
(Date:3/23/2017)... 2017 According to a report by Transparency ... fragmented due to the presence of a large pool of participants; ... Fisher , and Sigma-Aldrich, compete with each other in this market. ... more than 76% of this market in 2016.  ... As of now, a large number ...
(Date:3/23/2017)... 23, 2017 In today,s pre-market ... in the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), ... MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." ... report at: ...
Breaking Biology Technology:
(Date:2/22/2017)... , Feb. 22, 2017 With ... 2021, ABI Research identifies four technologies that innovative ... to secure significant share in the changing competitive ... and passive authentication.   "Companies can ... comes to security," says Dimitrios Pavlakis , ...
(Date:2/13/2017)... 2017  RSA Conference -- RSA, a Dell Technologies ... to enhance fraud detection and investigation across digital ... Fraud & Risk Intelligence Suite. The new platform ... insights from internal and external sources as well ... customers from targeted cybercrime attacks. "Fraudsters ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
Breaking Biology News(10 mins):